Shaily Engineering Plastics Stock Update: Healthcare mein entry ne Machaya Dhamal! Share **31%** Bhaga

INDUSTRIAL-GOODSSERVICES
Whalesbook Logo
AuthorIshaan Verma|Published at:
Shaily Engineering Plastics Stock Update: Healthcare mein entry ne Machaya Dhamal! Share **31%** Bhaga
Overview

Bhai log, Shaily Engineering Plastics ka stock three days mein around **31%** bhag gaya hai! Iske peeche reason hai company ka Q3FY26 ka zabardast result aur institutional investors ka trust. Plus, ye log healthcare devices mein entry maar rahe hain jisse **42%** revenue share ho gaya hai. Dekho, market jab gir raha tha tab bhi ye stock pakda.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Yaar, market toh waise bhi global tensions aur oil prices se pareshan hai. Lekin Shaily Engineering Plastics ne dikha diya ki kaise growth karte hain. Stock friday ko bhi 10% jump maara hai, aur pichhle teen din mein toh 31% upar gaya hai!

Healthcare Sector: Game Changer?

Asal mein, company ne apna focus uss sector par shift kiya hai jahan margins zyaada hain - woh hai healthcare devices. Iska proof dekhna hai toh Q3 FY26 results dekho. Healthcare segment se revenue contribution double hokar 42% ho gaya hai! Revenue overall 27% YoY badh kar ₹251 crore pahunch gaya hai aur EBITDA toh 43% jump kar gaya ₹66 crore par. Margin bhi 26.5% ho gaya, matlab 310 basis points ka sudhaar!

Future Ready: Abu Dhabi Plant & New Tech

Aur ye log rukne wale nahi hain. Abu Dhabi mein naya plant laga rahe hain jo Q4FY28 tak chalu ho jayega. Yeh plant saal mein 150 million units tak pen aur auto-injector bana payega. Isse GLP-1, insulin delivery systems jaise advanced therapies ki demand poori hogi. Global drug delivery market mein ye ek bada mauka hai.

Big Investors Ka Bharosa

Institutional investors bhi SEPL par full confidence dikha rahe hain. Ashish Kacholia ke paas already 3.22% stake hai, aur ab SMALLCAP World Fund ne bhi apna stake 2.14% badha kar 7.62% kar liya hai.

Valuation & Targets: Kya Kehte Hain Experts?

Haan, valuation thoda high lag sakta hai. P/E ratio 53.50x se 63.50x hai, jo Finolex Industries (23.79x) aur Time Technoplast (20.80x) se kaafi zyada hai. Lekin medical device sector ki growth dekho - 26.9% CAGR se $50.1 billion tak pahunchni hai. Isliye analysts ka bhi 'Strong Buy' rating hai aur target price ₹3,330 se ₹3,596 tak de rahe hain.

Potential Risks Toh Hain Hi

Abhi bhi kuch chizon ka dhyan rakhna hoga. Valuation zyada hai, TTM ROE 15-28% hai par average ROE 10.9% hai. Team ka average tenure 1.9 years hai. Consumer side mein kuch bade clients par depend karna padta hai. Aur global market mein oil price ya geopolitical tensions ka impact bhi ho sakta hai.

The Big Picture

Lekin overall, company healthcare manufacturing mein zabardast position mein hai. Abu Dhabi plant aur naye contracts se growth pakki lag rahi hai. Order book bhi strong hai. Toh SEPL ka future bright lag raha hai, dekhte hain ye rally kitni chalti hai!

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.